Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 44.35
-0.45 (-1.00%)
Nov 13, 2026, 1:30 PM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3 billion as of November 13, 2026. It is the 25,578th most valuable company in the world and the 1,365th biggest in Taiwan. Its market cap has decreased by 7.60% in one year.
Market Cap
3.00B
Enterprise Value
2.44B
Revenue
467.69M
Global Rank
Country Rank
#1,365 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.00B, an increase of 937.68%. That is a compound annual growth rate of 12.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 3.00B | -13.55% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.39B |
| Pharmosa Biopharm | 3.28B |
| Formosa Pharmaceuticals | 3.13B |
| Great Novel Therapeutics Biotech & Medicals | 3.07B |
| Shine-On BioMedical | 2.96B |
| BioGend Therapeutics | 2.74B |
| Intech Biopharm | 2.74B |